A61K 51/0404
Lipids
Official title: {Lipids, e.g. triglycerides; Polycationic carriers (polycationic carriers being oligomers, polymers, dendrimers A61K47/56; fatty acids A61K51/0402; cholesterol A61K51/0493)}
A61K51/0404 (Lipids) appears on 272 US grants and 325 published applications in this corpus.
Search patents in A61K- Granted patents
- 272
- Published applications
- 325
- Assignees
- 192
- Inventors
- 742
- Latest grant
- 31 Mar 2026
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 1980 | 1 | 0 |
| 1981 | 2 | 0 |
| 1982 | 8 | 0 |
| 1983 | 1 | 0 |
| 1984 | 2 | 0 |
| 1985 | 4 | 0 |
| 1986 | 5 | 0 |
| 1987 | 1 | 0 |
| 1988 | 0 | 0 |
| 1989 | 6 | 0 |
| 1990 | 9 | 0 |
| 1991 | 1 | 0 |
| 1992 | 4 | 0 |
| 1993 | 3 | 0 |
| 1994 | 3 | 0 |
| 1995 | 2 | 0 |
| 1996 | 2 | 0 |
| 1997 | 3 | 0 |
| 1998 | 7 | 0 |
| 1999 | 5 | 0 |
| 2000 | 7 | 0 |
| 2001 | 4 | 3 |
| 2002 | 8 | 7 |
| 2003 | 7 | 5 |
| 2004 | 2 | 7 |
| 2005 | 3 | 5 |
| 2006 | 3 | 9 |
| 2007 | 5 | 12 |
| 2008 | 3 | 11 |
| 2009 | 4 | 13 |
| 2010 | 9 | 12 |
| 2011 | 3 | 14 |
| 2012 | 10 | 15 |
| 2013 | 19 | 19 |
| 2014 | 17 | 19 |
| 2015 | 12 | 27 |
| 2016 | 17 | 18 |
| 2017 | 12 | 15 |
| 2018 | 11 | 12 |
| 2019 | 3 | 11 |
| 2020 | 9 | 16 |
| 2021 | 10 | 8 |
| 2022 | 8 | 19 |
| 2023 | 4 | 7 |
| 2024 | 3 | 11 |
| 2025 | 9 | 21 |
| 2026 | 1 | 9 |
By publication year. Applications have been published since 2001. 2026 runs to 8 Oct.
Subgroups
Granted patents
Recent patents
- Enantiomer selective action on neurotransmission31 Mar 2026US 12,589,087 B2The Board of Trustees of the Leland Stanford Junior University
- Sulfur (VI) fluoride compounds and methods for the preparation thereof19 Aug 2025US 12,390,424 B2The Scripps Research Institute
- PSMA binding dual mode radiotracer and therapeutic15 Jul 2025US 12,357,711 B2Technische Universität München
- Glutaminase inhibitor therapy24 Jun 2025US 12,336,976 B2Board of Regents, The University of Texas System
- Oligonucleotide conjugate with high hybridization performance and use thereof17 Jun 2025US 12,331,355 B2Daan Gene Co., Ltd.
- Combination for and method of suppressing sarcoma or carcinoma malignancies17 Sep 2026US 2026/0273109 A1Ism Biosciences LLC
- Gel compositions and related methods17 Sep 2026US 2026/0273113 A1Boston Scientific Scimed, Inc.
- Combination therapy for treating cancer3 Sep 2026US 2026/0256954 A1Ism Biosciences LLC
- Neurotensin receptor 1 (ntsr1) targeted therapeutics and uses thereof23 Jul 2026US 2026/0207797 A1Radionetics Oncology, Inc.
- Cgmp-compliant automated [18f]fspg production for clinical examination2 Jul 2026US 2026/0184667 A1
Most cited
By later US patents
- Compounds for cancer imaging and therapy114US 6,517,811 B2Research Corporation Technologies, Inc. · 2003
- Non-steroidal radiolabeled agonist/antagonist compounds and their use in prostate cancer imaging74US 6,019,957 AThe University of Tennessee Research Corporation · 2000
- Technetium—and rhenium-bis(heteroaryl) complexes and methods of use thereof62US 8,962,799 B2Molecular Insight Pharmaceuticals, Inc. · 2015
- Labeled fatty acids and method of making and using same54US 4,323,547 AKernforschungsanlage Julich Gesellschaft mit beschrankter Haftung · 1982
- Homocysteine and homocysteinamide derivatives52US 4,571,430 AMedi-Physics, Inc. · 1986